I see in the news that both Novartis and Kite made CAR-T applications for blood cancers during the last week of March 2017.
USA PC trial:
/clinicaltrials.gov/ct2/show/NCT03089203Epcam trial in China below.
/clinicaltrials.gov/ct2/show/NCT03013712Post Edited (RobertC) : 4/1/2017 8:58:35 AM (GMT-6)